Guanidino compounds as uremic (neuro)toxins

Seminars in Dialysis

Volumn 22, Issue 4, 2009, Pages 340-345

  De Deyn, Peter Paul ^a,b   Vanholder, Raymond ^c   Eloot, Sunny ^c   Glorieux, Griet ^c  

^a ZNA Middelheim Hospital   (Belgium)

^b UNIVERSITY OF ANTWERP   (Belgium)

^c GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

GUANIDINE DERIVATIVE; TOXIN;

ARTICLE; BRAIN; DRUG EFFECT; HUMAN; METABOLISM; PSYCHOLOGICAL ASPECT; UREMIA;

BRAIN; GUANIDINES; HUMANS; TOXINS, BIOLOGICAL; UREMIA;

EID: 69249155619     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2009.00577.x     Document Type: Article

References (39)

1. Brouns R, De Deyn PP : Neurological complications in renal failure: a review. Clin Neurol Neurosurg 107 : 1 16, 2004
2. De Deyn PP, Marescau B, Cuykens JJ, Van Gorp L, Lowenthal A : Guanidino compounds in serum and cerebrospinal fluid of nondialyzed patients with renal insufficiency. Clin Chim Acta 167 : 81 88, 1987
3. De Deyn PP, Marescau B, D'Hooge R, Possemiers I, Nagler J, Mahler C : Guanidino compound levels in brain regions of non-dialyzed uremic patients. Neurochem Int 27 : 227 237, 1995
4. De Deyn PP, Marescau B, Lornoy W, Becaus I, Lowenthal A : Guanidino compounds in uraemic dialyzed patients. Clin Chim Acta 157 : 143 150, 1986
5. De Deyn PP, Marescau B, Lornoy W, Becaus I, Van Leuven I, Van Gorp L, Lowenthal A : Serum guanidino compound levels and the influence of a single hemodialysis in uremic patients undergoing maintenance hemodialysis. Nephron 45 : 291 295, 1987
6. Giovannetti S, Cioni L, Balestri PL, Biagini M : Evidence that guanidines and some related compounds cause haemolysis in chronic uraemia. Clin Sci 34 : 141 148, 1968
7. Stein IM, Cohen BD : Guanidinosuccinic acid in renal failure, experimental azotemia and inborn errors of the urea cycle. N Engl J Med 280 : 826 930, 1969
8. Vanholder R, Glorieux G, De Smet R, Lameire N : European Uremic Toxin Work Group. New insights in uremic toxins. Kidney Int Suppl 84 : S6 S10, 2003
9. De Deyn PP, D'Hooge R, Van Bogaert PP, Marescau B : Endogenous guanidino compounds as uremic neurotoxins. Kidney Int Suppl 78 : S77 S83, 2001
10. Marescau B, Nagels G, Possemiers I, De Broe ME, Becaus I, Billiouw JM, Lornoy W, De Deyn PP : Guanidino compounds in serum and urine of nondialysed patients with chronic renal insufficiency. Metabolism 46 : 1024 1031, 1997
11. Glorieux G, Cohen G, Jankowski J, Vanholder R : Platelet/leukocyte activation, inflammation and uremia. Semin Dial 22, 2009
12. Kielstein JT, Fliser D, Veldink H : Asymmetric dimethylarginine and symmetric dimethylarginine: axis of evil or useful alliance? Semin Dial 22, 2009
13. Zoccali C, Bode-Boger S, Mallamaci F, Benedetto F, Tripepi G, Malatino L, Cataliotti A, Bellanuova I, Fermo I, Frolich J, Boger R : Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study. Lancet 358 : 2113 2117, 2001
14. Glorieux GL, Dhondt AW, Jacobs P, Van Langeraert J, Lameire NH, De Deyn PP, Vanholder RC : In vitro study of the potential role of guanidines in leukocyte functions related to atherogenesis and infection. Kidney Int 65 : 2184 2192, 2004
15. Schepers E, Glorieux G, Dhondt AW, Leybaert L, Vanholder R : Role of symmetric dimethylarginine in vascular damage by increasing ROS production via store-operated calcium-influx in monocytes. Nephrol Dial Transplant (In Press).
16. Perna AF, Ingrosso D, Satta E, Lombardi C, Galletti P, D'aniello A, De Santo NG : Plasma protein aspartyl damage is increased in hemodialysis patients: Studies on causes and consequences. J Am Soc Nephrol 15 : 2747 2754, 2004
17. Torremans A, D'Hooge R, Van de Vijver G, Marescau B, Vanholder R, Lameire N, De Deyn PP, Van Bogaert PP : Effect of NaCN on currents evoked by uremic retention solutes in dissociated mouse neurons. Brain Res 1008 : 107 112, 2004
18. Horowitz HI, Cohen BD, Martinez P, Papayoanou MF : Defective ADP-induced platelet factor 3 activation in uremia. Blood 30 : 331 340, 1967
19. Stein IM, Cohen BD, Horowitz HI : Guanidinosuccinic acid: the "X" factor in uremic bleeding? Clin Res 16 : 397, 1968
20. Giovannetti S, Balestri PL, Barsotti G : Methylguanidine in uremia. Arch Intern Med 131 : 709 717, 1973
21. Giovannetti S, Biagini M, Balestri PL, Navalesi R, Giagnoni P, De Matteis A, Ferro-Milone P, Perfetti C : Uremia-like syndrome in dogs chronically intoxicated with methylguanidine and creatinine. Clin Sci 36 : 445 452, 1969
22. Matsumoto M, Mori A : Convulsive activity of methylguanidine in cat and rabbits. IRCS Med Sci 4 : 65, 1976
23. Jinnai D, Mori A, Mukawa J, Ohkusu H, Hosotani M, Mizuno A, Tye L : Biochemical and physiological studies on guanidino compounds induced convulsions. Jpn J Brain Physiol 106 : 3668 3673, 1969
24. Mori A : Biochemistry and neurotoxicology of guanidino compounds. History and recent advances. Pav J Biol Sci 22 : 85 94, 1987
25. Yokoi I, Toma J, Mori A : The effects of homoarginine on the EEG of rats. Neurochem Pathol 2 : 295 300, 1984
26. Minkoff L, Gaerther G, Darab M, Mercier C, Levin ML : Inhibition of brain sodium-potassium ATPase in uremic rats. J Lab Clin Med 80 : 71 78, 1972
27. D'Hooge R, Pei Y-Q, Marescau B, De Deyn PP : Convulsive action and toxicity of uremic guanidino compounds: behavioral assessment and relation to brain concentration in adult mice. J Neurol Sci 112 : 96 105, 1992
28. D'Hooge R, Pei Y-Q, Manil J, De Deyn PP : The uremic guanidino compound guanidinosuccinic acid induces behavioral convulsions and concomitant epileptiform electrocorticographic discharges in mice. Brain Res 598 : 316 320, 1992
29. De Deyn PP, Macdonald RL : Guanidino compounds that are increased in cerebrospinal fluid and brain of uremic patients inhibit GABA and glycine responses on mouse neurons in cell culture. Ann Neurol 28 : 627 633, 1990
30. D'Hooge R, De Deyn PP, Van de Vijver G, Antoons G, Raes A, Van Bogaert PP : Uraemic guanidino compounds inhibit γ-aminobutyric acid-evoked whole-cell currents in mouse spinal cord neurones. Neurosci Lett 265 : 83 86, 1999
31. D'Hooge R, Pei Y-Q, De Deyn PP : N-Methyl-D-aspartate receptors contribute to guanidinosuccinate-induced convulsions in mice. Neurosci Lett 157 : 123 126, 1993
32. Reynolds IJ, Rothermund K : Multiple modes of NMDA receptor regulation by guanidines. In : De Deyn PP, Marescau B, Stalon V, Qureshi IA (eds). Guanidino Compounds in Biology and Medicine. London : John Libbey, 1992 : 441 448
33. D'Hooge R, Raes A, Lebrun P, Diltoer M, Van Bogaert PP, Manil J, Colin F, De Deyn PP : N-Methyl-D-aspartate receptor activation by guanidinosuccinate but not by methylguanidine: behavioral and electrophysiological evidence. Neuropharmacology 35 : 433 440, 1996
34. D'Hooge R, Manil J, Colin F, De Deyn PP : Guanidinosuccinic acid inhibits excitatory synaptic transmission in CA1 region of rat hippocampal slices. Ann Neurol 30 : 622 623, 1991
35. Pan JC, Pei Y-Q, An L, Lai L, D'Hooge R, De Deyn PP : Epileptiform activity and hippocampal damage produced by intrahippocampal injection of guanidinosuccinic acid in rat. Neurosci Lett 209 : 121 124, 1996
36. Torremans A, Marescau B, Van Dam D, Van Ginneken C, Van Meir F, Van Bogaert PP, D'Hooge R, de Vente J, De Deyn PP : GSA: behavioral, histological, electrophysiological and neurochemical effects. Physiol Behav 84 : 251 264, 2005
37. Collingridge GL, Lester RAJ : Excitatory amino acid receptors in the vertebrate central nervous system. Pharmacol Rev 40 : 143 210, 1989
38. Eloot S, Torremans A, De Smet R, Marescau B, De Wachter D, De Deyn PP, Lameire N, Verdonck P, Vanholder R : Kinetic behavior of urea is different from that of other water-soluble compounds: the case of the guanidino compounds. Kidney Int 67 : 1566 1575, 2005
39. Eloot S, Torremans A, De Smet R, Marescau B, De Deyn PP, Verdonck P, Vanholder R : Complex compartmental behavior of small water-soluble uremic retention solutes: evaluation by direct measurements in plasma and erythrocytes. Am J Kidney Dis 50 : 181 183, 2007